ACUPHARMA ApS: Financial statements 2018
CVR: 10072956
Source: annual report 2018, Danish Business Authority
01/10/2017 – 30/09/2018
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,724,257 and a net result of DKK 5,216 compared with DKK 80,359 the year before. That is an increase of 13.9% compared with the year before. Equity in the 2018 report amounted to DKK 153,966. The solvency ratio was 4.7%.
- Gross Profit
- DKK 1,724,257
- Profit/Loss
- DKK 5,216
- Equity
- DKK 153,966
- Total Assets
- DKK 3,258,412
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.7 mio. | 5 t. | 154 t. | - |
| 2017 | - | 1.5 mio. | 80 t. | 149 t. | - |
| 2016 | - | 1.1 mio. | 105 | 68 t. | - |
| 2015 | - | 322 t. | -360 t. | 68 t. | - |
| 2014 | - | 1.4 mio. | 551 t. | 773 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ACUPHARMA ApS has published its annual report for 2017. Gross profit came to DKK 1,513,402, and the net result was DKK 80,359.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.